Cornford E M, Braun L D, Crane P D, Oldendorf W H
Endocrinology. 1978 Oct;103(4):1297-303. doi: 10.1210/endo-103-4-1297.
Blood-brain barrier penetration of leucine-enkephalin, methionine-enkephalin, and other peptide-like compounds was measured after intracarotid injection of three isotopes and was found to be non-saturable over the nanomolar range of concentrations tested. No significant differences in brain regional extraction of leucine enkephalin (or morphine or heroin) were observed. In contrast to previous reports, the brain extraction of enkephalins was minimally low (E = 2-3%) and about the same order of magnitude as other putative neurotransmitters. Brain extractions of other peptide-like compounds were similarly small: TRH, E = 1%; glutathione, E = 0.5%; beta-alanyl histidine, E = 1%; and thioacetyl coenzyme A, E = 2%. Extraction of the non-diffusible reference dextran was determined to be 1%, suggesting that the blood brain barrier tends to restrict peptide penetration.
在颈内注射三种同位素后,测定了亮氨酸脑啡肽、甲硫氨酸脑啡肽及其他肽类化合物的血脑屏障通透性,发现在所测试的纳摩尔浓度范围内其无饱和现象。未观察到亮氨酸脑啡肽(或吗啡或海洛因)在脑区摄取上的显著差异。与先前的报道相反,脑啡肽的脑摄取极低(E = 2 - 3%),与其他假定的神经递质处于相同数量级。其他肽类化合物的脑摄取同样很低:促甲状腺激素释放激素(TRH),E = 1%;谷胱甘肽,E = 0.5%;β - 丙氨酰组氨酸,E = 1%;硫代乙酰辅酶A,E = 2%。不可扩散的参比葡聚糖的摄取率测定为1%,表明血脑屏障倾向于限制肽的通透。